![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1402730
ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¿¹Ãø(-2030³â) - Áö¿ªº° ºÐ¼® : Á¦Ç°, ¼ö¹ý, ÃÖÁ¾ »ç¿ëÀÚNorth America Dental Bone Graft Substitute and Barrier Membrane Market Forecast to 2030 - Regional Analysis - Product (Dental Bone Graft Substitute and Dental Barrier Membrane), Procedures, and End User (Hospitals, Dental Clinics, and Others) |
ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº 2022³â 2¾ï 9,365¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 5¾ï 5,238¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2022³âºÎÅÍ 2030³â±îÁö CAGRÀº 8.2%·Î Àü¸ÁµË´Ï´Ù.
½ÃÀå °³Ã´: ºÏ¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀ» ¿î¿µÇÏ´Â ½ÃÀå ÁøÃâ±â¾÷ÀÇ Àü·«Àû Àü°³
Á¦Ç° ÅõÀÔ, M&A, »ç¾÷ È®´ë µî ½ÅÈï±¹ ½ÃÀå °³Ã´ Àü·«Àº ºÏ¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÕ´Ï´Ù. 2023³â 4¿ù, ZimVie´Â RegenerOss CC Allograft Particulate¿Í RegenerOss Bone Graft PlugÀÇ Ãâ½Ã¸¦ ¹ßÇ¥ÇÏ¿© ¹ßÄ¡¿Í Ä¡ÁÖ °á¼Õ ÃæÀüÀ» ¸ñÀûÀ¸·Î ÇÏ´Â »ýüÀç·á Æ÷Æ®Æú¸®¿À¸¦ È®ÃæÇß½À´Ï´Ù. ÀÌ Á¦Ç°µéÀº ºÏ¹Ì¿¡¼ ½ÃÆÇµÇ°í ÀÖ½À´Ï´Ù. 2023³â 5¿ù, ½ºÆ®¶ó¿ì¸ÕÀº ½ºÀ§½ºÀÇ ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ GalvoSurge Dental AG¸¦ ÀμöÇß½À´Ï´Ù. ÀμöÇÑ È¸»ç´Â ÀÓÇöõÆ® ÁÖº¯¿°ÀÇ Ä¡·á¸¦ Áö¿øÇÏ´Â ÀÓÇöõÆ® °ü¸® ¹× À¯Áöº¸¼ö ¼Ö·ç¼ÇÀ» Àü¹®À¸·Î ÇÕ´Ï´Ù. 2022³â 10¿ù, »À, ¿¬°ñ, Á¶Á÷ÀÇ Àç»ýÀ» Àü¹®À¸·Î ÇÏ´Â °¡À̽ºÆ®¸®È÷»ç´Â ¹Ì±¹ÀÇ ¸°Ä¡ ¹ÙÀÌ¿À·ÎÁ÷½º»ç¸¦ Àμö. ÀÌ Àμö¸¦ ÅëÇØ °¡À̽ºÆ®¸®È÷ ÆÄ¸¶´Â ¸°Ä¡ ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ ÁÖ¿ä Á¦Ç°ÀÎ GEM 21S¸¦ Æ÷Æ®Æú¸®¿À¿¡ Ãß°¡ÇÏ¿© Æ÷Æ®Æú¸®¿À¸¦ °ÈÇß½À´Ï´Ù. GEM 21S´Â »À Çü¼º°ú »óó Ä¡À¯¸¦ ÃËÁøÇÏ´Â ¼ºÀå ÀÎÀÚ¸¦ ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.
¾ç»ç´Â ¶ÇÇÑ Ä¡°ú¿¡¼ Àç»ý ±â¼úÀÇ Çõ½ÅÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. 2022³â 12¿ù, Ä¡°ú ÀÓÇöõÆ® Ä¡·áÁ¦Ç°ÀÇ ¼³°è, Á¦Á¶ ¹× ÆÇ¸Å¸¦ ½Ç½ÃÇÏ´Â ³×¿À½º¡¤±×·ìÀº ºÏÀ¯·´¿¡ »õ·Î¿î ¿µ¾÷ °ÅÁ¡À» °³¼³Çß½À´Ï´Ù. 2022³â 12¿ù 01ÀÏ¿¡ ºÏÀ¯·´¿¡¼ ¿µ¾÷À» ½ÃÀÛÇß½À´Ï´Ù. 2021³â 1¿ù, µ§Ã÷ÇöóÀÌ ½Ã·Î³ª´Â Çõ½ÅÀûÀÎ OSSIX Àç»ý ¼Ö·ç¼ÇÀÇ ¼±µÎ °ø±Þ¾÷üÀÎ Datum DentalÀ» ÀμöÇß½À´Ï´Ù. ÀÌ Àμö·Î µ§Ã÷ÇÁ¶óÀ̽÷γª´Â µ¥ÀÌÅÒ µ§Å»»çÀÇ °·ÂÇÑ OSSIX ¹ÙÀÌ¿À¸ÓƼ¸®¾ó Æ÷Æ®Æú¸®¿À¸¦ ȹµæÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù. ¶ÇÇÑ µ§ÅÒµ§Å»»çÀÇ Æ¯Çã±â¼úÀÎ GLYMATRIX¿¡ ´ëÇÑ ¾×¼¼½ºµµ °¡´ÉÇÏ°Ô µÇ¾ú½À´Ï´Ù. GLYMATRIX´Â ½ÅüÀÇ ÀÚ¿¬ÀûÀÎ Äݶó°Õ »çÀÌŬ, Áï ´çȶó°í ºÒ¸®´Â »ýÈÇÐÀû °úÁ¤À» ¸ð¹æÇÕ´Ï´Ù. GLYMATRIX´Â °¡À̵å Çϰñ Àç»ý ¹× °¡À̵å ÇÏ Á¶Á÷ Àç»ýÀ» À§ÇÑ OSSIX Á¦Ç°ÀÇ ±âÃʸ¦ Çü¼ºÇÕ´Ï´Ù.
ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå °³¿ä
ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°°ú ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼´Â ¹Ì±¹ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ ½ÃÀåÀÇ ¼ºÀåÀº Àü±¹ Ä¡°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¤±âÀûÀÎ Ä¡°ú °ËÁø, ±â¼ú °³¼± µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù.
ºÏ¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼öÀͰú 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)
ºÏ¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼¼ºÐÈ
ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Á¦Ç°, ±â¹ý, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ºÐÇҵ˴ϴÙ.
Á¦Ç°¿¡ µû¶ó ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°°ú Ä¡°ú¿ë ¹è¸®¾î ¸âºê·¹ÀÎÀ¸·Î À̺е˴ϴÙ. Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ºÎ¹®Àº 2022³â ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼ ´õ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
Ä¡·á¿¡ µû¶ó ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº °¡À̵å Çϰñ Àç»ý(GBR) Ä¡·á, °¡À̵å ÇÏÁ¶Á÷ Àç»ý(GTR) Ä¡·á, »çÀ̳ʽº ¸®ÇÁÆ® ¹× ¸´Áö ½ºÇø´ Ä¡·á, Ä¡Á¶°ñ À¶±â º¸Á¸(ARP), ºí·Ï ±×·¡ÇÁÆ® ó¸®, Ä¡ÁÖ Àç»ý ó¸®, ¼ÒÄÏ º¸Á¸ µîÀ¸·Î ±¸ºÐµË´Ï´Ù. 2022³â ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼ »çÀ̳ʽº ¸®ÇÁÆ®¿Í ¸´Áö ºÐÇÒ ºÎ¹®Àº °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚ¸¦ ±â¹ÝÀ¸·Î ºÏ¹ÌÀÇ, Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº º´¿ø, Ä¡°ú Ŭ¸®´Ð µîÀ¸·Î ±¸ºÐµË´Ï´Ù. Ä¡°ú Ŭ¸®´Ð ºÎ¹®Àº 2022³â ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î, ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°°ú ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. ¹Ì±¹Àº 2022³â ºÏ¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°°ú ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regensity Biosciences Inc, Neoss UK &Ireland Ltd, Institut Straumann AG, Resorba Medical GmbH°¡ ºÏ¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× À庮 ¸âºê·¹ÀÎ ½ÃÀå¿¡¼ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.
The North America dental bone graft substitute and barrier membrane market is expected to grow from US$ 293.65 million in 2022 to US$ 552.38 million by 2030. It is estimated to grow at a CAGR of 8.2% from 2022 to 2030.
Strategic Developments by Market Players Fuel North America Dental Bone Graft Substitute and Barrier Membrane Market
Development strategies such as product launches, mergers and acquisitions, and expansions boost the growth of the North America Dental Bone Graft Substitute and Barrier Membrane Market . In April 2023, ZimVie announced the launch of RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, which helped it extend its portfolio of biomaterials that are intended for filling extraction sockets and periodontal defects. The products are commercially available in North America. In May 2023, Straumann acquired GalvoSurge Dental AG, a Swiss medical device manufacturer. The acquired company specializes in implant care and maintenance solutions to support the treatment of peri-implantitis. In October 2022, Geistlich, specialized in the regeneration of bone, cartilage, and tissue, acquired Lynch Biologics, US. The acquisition helped Geistlich Pharma to strengthen its portfolio by adding Lynch Biologics, LLC's leading GEM 21S product to it. GEM 21S is based on a growth factor that accelerates bone formation and wound healing.
The companies further aim to innovate regenerative technologies in dentistry. In December 2022, Neoss Group, which designs, manufactures, and sells dental implant treatment products, opened a new sales office in the Nordic region. The facility commenced operations in the Nordic region on December 01, 2022, to support dental professionals and their patients. In January 2021, Dentsply Sirona acquired Datum Dental, a leading provider of innovative OSSIX regenerative solutions. The acquisition enabled Dentsply Sirona to acquire the strong OSSIX biomaterial portfolio of Datum Dental, Ltd. It also offered it access to the patented GLYMATRIX technology of Datum Dental Ltd. GLYMATRIX mimics the natural collagen cycle in the body, i.e., a biochemical process called glycation. GLYMATRIX forms the basis of OSSIX products for guided bone regeneration, as well as guided tissue regeneration.
North America Dental Bone Graft Substitute and Barrier Membrane Market Overview
The North America North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US is expected to account for the largest share of the North America Dental Bone Graft Substitute and Barrier Membrane Market. The growth of the market in the US is attributed to the rise in the prevalence of dental diseases across the country, regular dental check-ups, and technological improvements.
North America Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)
North America Dental Bone Graft Substitute and Barrier Membrane Market Segmentation
The North America dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user and country.
Based on product, the North America dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the North America dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the North America dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on country, the North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US dominated the North America dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, and Resorba Medical GmbH are the leading companies operating in the North America dental bone graft substitute and barrier membrane market.